抗菌导管与贝朗普通中心静脉置管在重症监护室患者中的疗效对比  

The antibacterial catheter of Saituoanbao and common central venous catheter of braun in ICU

作　　者：李晓玉[1] 张川[1] 曾薇[1] 

机构地区：[1]成都市第三人民医院ICU科,四川成都610031

出　　处：《中国医学装备》2015年第3期87-89,共3页China Medical Equipment

摘　　要：目的:探讨赛托安保抗菌导管与贝朗普通中心静脉置管在重症监护室(ICU)患者应用的疗效对比。方法:选取ICU病房110例留置中心静脉导管患者,随机将其分为对照组和观察组,每组55例。对照组采用贝朗普通中心静脉导管,观察组采用赛托安保抗菌导管,并对两组一次置管成功率、平均留置天数、并发症、导管相关性感染(CRI)发生率及病原菌分布情况进行观察和比较。结果:与对照组相比,观察组一次置管成功率明显升高,差异有统计学意义(x2=11.00,P<0.05);平均留置天数明显缩短,差异有统计学意义(t=3.49,P<0.05);并发症发生率(穿刺部位红肿)相比,差异有统计学意义(x2=11.76,P<0.05);穿刺部位渗液相比,差异有统计学意义(x2=8.18,P<0.05);导管脱出均显著降低,差异有统计学意义(x2=9.35,P<0.05)。结论:抗菌导管能够明显降低重症监护室患者CRI发生率,提高中心静脉导管留置的安全性。Objective： To study the efficacy comparison between the antibacterial catheter and common central venous catheter in ICU patients. Methods： The 110 ICU patients with central venous catheter were randomized into the control group（common central venous catheter）and the observation group（antibacterial catheter）, 55 patients per group. The success rate of catheter, the averange catheter days, complications, and the incidence of catheter-related infection（CRI）and pathogen distribution in the two groups were observed and compared. Results： Compared with the control group, the success rate of catheter was significantly increased（100.0% vs 81.8%, x2=11.00, P0.05）, the averange catheter days were obviously reduced（12.5±3.0 vs 13.5±3.0, t=3.49, P0.05）days, the incidences of complications（red and swelling in puncture site（3.6% vs 27.3%, x2=11.76, P0.05）, fluid in puncutre site（3.6% vs 21.8%, x2=8.18, P0.05）, catheter herniation（1.8% vs 20.0%, x2=9.35, P0.05）were significantly decreased in the observation group with statistical difference（P0.05）. Conclusion： The antibacterial catheter can significantly reduce the incidence of CRI for ICU patients and improve the security of central venous catheter.

关 键 词：赛托安保抗菌导管 普通中心静脉导管 导管相关性感染 

分 类 号：R197.39[医药卫生—卫生事业管理]